Hem/Onc Roundup: Providing Cancer Care Amid COVID-19 Outbreak, AI Skin Cancer Screenings, and more

Here are the top stories covered by DocWire News this week in the Hematology & Oncology section. This week, experts shared advice on providing optimal cancer care during the COVID-19 pandemic, a study found that patients with cancer have an increased risk of cardiovascular disease, and more.

A team of experts from Seattle Cancer Care are sharing insights and advice on how to provide optimal cancer care amid the COVID-19 pandemic. The peer-reviewed article sharing best practices is available for free online-ahead-of-print via open access at JNCCN.org.

The use of artificial intelligence in health care is becoming more widespread, but how patients feel about it is a question up for debate. A new study found that when it comes to skin cancer screening, patients may be receptive to its use.

An estimated 20% of breast cancer patients develop lymphedema, which causes swelling of the arms. Researchers recently assessed the value of an app to detect and monitor lymphedema.

Patients with cancer have a more than twofold risk of developing atrial fibrillation compared with the general population, according to a press release regarding data that will be published by the American College of Cardiology’s Annual Scientific Session.

In case you missed it, more hem/onc headlines are featured below: